| Literature DB >> 35651949 |
Lifeng Ma1,2, Hui Chen1,2, Zhiying Zhang1,2, Lijun Liu1,2, Yiduo Zhao1,2, Yansong Li1,2, Zhipeng Zhao1,2, Haitao Chen3, Longli Kang1,2.
Abstract
Background: The incidence of gallstones in the Tibetan population is increasing rapidly. Previous studies indicated that genetic variation located in the cholesterol metabolism pathway may be associated with the incidence of gallstones.Entities:
Keywords: FXYD2; Tibetans; cholesterol; gallstones; single nucleotide polymorphism
Year: 2022 PMID: 35651949 PMCID: PMC9149373 DOI: 10.3389/fgene.2022.902553
Source DB: PubMed Journal: Front Genet ISSN: 1664-8021 Impact factor: 4.772
FIGURE 1Principal component analysis in (A) the Chinese Tibetan population and (B) the reference sample in the international 1,000 genomes project. Case, Patients with gallstones; Control, Healthy control population; CEU, Utah Residents (CEPH) with Northern and Western European Ancestry; CHB, Han Chinese in Beijing, China; YRI, Yoruba in Ibadan, Nigeria.
FIGURE 2Quantile-Quantile Plot of gallstones. (A) does not correct the eigen vector, (B) correct for the first eigen vector, (C) correct for the top 2 eigen vectors and (D) correct for the top 5 eigen vectors. Solid lines indicate the null-hypothesis.
FIGURE 3Manhattan Plot of gallstones for (A) Cases vs. all controls (our 52 controls +41 public controls), (B) Cases. our 52 controls and (C) Cases vs. 41 public controls. The plot shows −log10 p value for each SNP against the chromosomal location. The x-axis represents chromosomal position and the y-axis shows −log10 p values. The blue dashed line indicates the p value of 0.05 while the solid red line indicates the p value of 0.01.
Overall and subgroup analyses for SNPs which were significantly associated with gallstone (FDR-P < 0.2).
| SNP | Chr | BP | Gene | MA | Case genotype | Control genotype | OR (95% CI) |
| ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| mm | Mm | MM | mm | Mm | MM | |||||||
| Cases vs. All controls | ||||||||||||
| SNV05997 | 2 | 74,450,135 | SLC4A5 | G | 0 | 108 | 24 | 0 | 42 | 51 | 5.43 (2.95–9.98) | 5.30E-08 |
| rs80145081 | 3 | 195,510,732 | MUC4 | A | 0 | 103 | 25 | 0 | 43 | 47 | 4.19 (2.27–7.73) | 4.56E-06 |
| rs80005560 | 3 | 195,510,718 | MUC4 | T | 0 | 103 | 28 | 0 | 44 | 49 | 3.78 (2.08–6.87) | 1.35E-05 |
| rs79074685 | 7 | 117,188,850 | CFTR | T | 0 | 11 | 121 | 0 | 31 | 62 | 0.19 (0.09–0.4) | 1.47E-05 |
| rs748546375 | 16 | 53,913,912 | FTO | C | 0 | 84 | 48 | 0 | 31 | 62 | 3.46 (1.97–6.1) | 1.67E-05 |
| rs201880593 | 7 | 117,188,750 | CFTR | T | 0 | 7 | 125 | 0 | 27 | 66 | 0.14 (0.06–0.35) | 2.02E-05 |
| rs142559357 | 3 | 195,510,707 | MUC4 | G | 0 | 103 | 28 | 0 | 45 | 46 | 3.49 (1.92–6.36) | 4.44E-05 |
| rs750769471 | 18 | 21,120,382 | NPC1 | G | 0 | 95 | 36 | 0 | 44 | 49 | 2.74 (1.55–4.84) | 5.05E-04 |
| |
|
|
|
|
|
|
|
|
|
|
|
|
| rs4072341 | 5 | 7,757,705 | ADCY2 | C | 1 | 12 | 115 | 5 | 20 | 65 | 0.33 (0.17–0.63) | 7.87E-04 |
| Cases vs. Our control | ||||||||||||
| SNV05997 | 2 | 74,450,135 | SLC4A5 | G | 0 | 108 | 24 | 0 | 42 | 10 | 1.06 (0.46–2.42) | 8.96E-01 |
| rs80145081 | 3 | 195,510,732 | MUC4 | A | 0 | 103 | 25 | 0 | 38 | 11 | 1.11 (0.49–2.50) | 8.02E-01 |
| rs80005560 | 3 | 195,510,718 | MUC4 | T | 0 | 103 | 28 | 0 | 38 | 14 | 1.23 (0.58–2.63) | 5.90E-01 |
| rs79074685 | 7 | 117,188,850 | CFTR | T | 0 | 11 | 121 | 0 | 2 | 50 | 2.46 (0.52–11.71) | 2.60E-01 |
| rs748546375 | 16 | 53,913,912 | FTO | C | 0 | 84 | 48 | 0 | 28 | 24 | 1.49 (0.77–2.87) | 2.34E-01 |
| rs201880593 | 7 | 117,188,750 | CFTR | T | 0 | 7 | 125 | 0 | 3 | 49 | 0.97 (0.24–3.95) | 9.66E-01 |
| rs142559357 | 3 | 195,510,707 | MUC4 | G | 0 | 103 | 28 | 0 | 38 | 14 | 1.23 (0.58–2.63) | 5.92E-01 |
| rs750769471 | 18 | 21,120,382 | NPC1 | G | 0 | 95 | 36 | 0 | 38 | 14 | 0.91 (0.44–1.90) | 7.99E-01 |
| |
|
|
|
| 15 | 57 | 60 | 3 | 14 | 35 |
|
|
| rs4072341 | 5 | 7,757,705 | ADCY2 | C | 1 | 12 | 115 | 0 | 3 | 47 | 1.72 (0.50–6.00) | 3.92E-01 |
| Cases vs. Public control | ||||||||||||
| SNV05997 | 2 | 74,450,135 | SLC4A5 | G | 0 | 108 | 24 | 0 | 0 | 41 | — | 2.88E-12 |
| rs80145081 | 3 | 195,510,732 | MUC4 | A | 0 | 103 | 25 | 0 | 5 | 36 | 29.59 (10.10–86.72) | 6.61E-10 |
| rs80005560 | 3 | 195,510,718 | MUC4 | T | 0 | 103 | 28 | 0 | 6 | 35 | 22.33 (8.03–62.07) | 2.63E-09 |
| rs79074685 | 7 | 117,188,850 | CFTR | T | 0 | 11 | 121 | 0 | 29 | 12 | 0.03 (0.01–0.09) | 6.11E-12 |
| rs748546375 | 16 | 53,913,912 | FTO | C | 0 | 84 | 48 | 0 | 3 | 38 | 21.98 (6.37–75.84) | 1.01E-06 |
| rs201880593 | 7 | 117,188,750 | CFTR | T | 0 | 7 | 125 | 0 | 24 | 17 | 0.04 (0.01–0.11) | 4.29E-10 |
| rs142559357 | 3 | 195,510,707 | MUC4 | G | 0 | 103 | 28 | 0 | 7 | 32 | 17.39 (6.56–46.12) | 9.43E-09 |
| rs750769471 | 18 | 21,120,382 | NPC1 | G | 0 | 95 | 36 | 0 | 6 | 35 | 14.24 (5.48–37.03) | 5.08E-08 |
| |
|
|
|
| 15 | 57 | 60 | 0 | 14 | 27 |
|
|
| rs4072341 | 5 | 7,757,705 | ADCY2 | C | 1 | 12 | 115 | 5 | 17 | 18 | 0.12 (0.05–0.26) | 1.85E-07 |
MA, Minor Allele.
mm-Minor allele homozygous, Mm-Major and minor allele heterzygous, MM-Major allele homozygous.
Original p values after adjusting top 2 eigen vectors.
Bold values indicates statistical significance in all three cohorts.